A new frontier in pharmacology: the endoplasmic reticulum as a regulated export pathway in health and disease

Bibliography

• ARIDOR M, BALCH WE: Integration of endoplasmic reticulum signaling in health and disease. Nat. Med. (1999) 5:745–751.
   PubMed Web of Science ®Google Scholar
• ARIDOR M, HANNAN LA: Traffic jam: a compendium of human diseases that affect intracellular transport processes. Traffic (2000) 1:836–851.
   PubMed Web of Science ®Google Scholar
• ••A comprehensive review of diseases affecting proteintrafficking.
   Google Scholar
• RIORDAN JR, ROMMENS JM, KEREM B et al: Identifica-tion of the cystic fibrosis gene: cloning and characteri-zation of complementary DNA [published erratum appears in Science 1989 Sep 29;245(4925):1437]. Science (1989) 245:1066–1073.
   PubMed Web of Science ®Google Scholar
• KOPITO RR: Biosynthesis and degradation of CF1R. Physic)]. Rev. (1999) 79:S167–173.
   PubMed Web of Science ®Google Scholar
• QU D, TECKMAN JH, PERLMUTTER DH: Alpha 1-antitrypsin deficiency associated liver disease. J. Gastroenterol Hepatol. (1997) 12:404–416.
   PubMed Web of Science ®Google Scholar
• SIFERS RN, FINEGOLD MJ, WOO SLC: Molecular biology and genetics of alpha1-antitrypsin deficiency. Sem. Liver Disease (1992) 12:301–310.
   PubMed Web of Science ®Google Scholar
• KUHN L: Iron overload: molecular clues to its cause. Trends Biochem. Sci. (1999) 24:164–166.
   PubMed Web of Science ®Google Scholar
• SHELNESS GS, INGRAM MF, HUANG XF, DELOZIER JA: Apolipoprotein B in the rough endoplasmic reticulum: translation, translocation and the initiation of lipoprotein assembly. J. Nutr. (1999) 129:456S–462S.
   Google Scholar
• JOHNSTON JA, WARD CL, KOPITO RR: Aggresomes: a cellular response to misfolded proteins. J Cell Biol. (1998) 143:1883–1898.
   PubMed Web of Science ®Google Scholar
• TABARY O, ESCOTTE S, COUETIL JP et al.: Genistein inhibits constitutive and inducible NFkappaB activa-tion and decreases IL-8 production by human cystic fibrosis bronchial gland cells. Am. J Pathol. (1999) 155:473–481.
   PubMed Web of Science ®Google Scholar
• DIMANGO E, RATNER AJ, BRYAN R, TABIBI S, PRINCE A: Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin. Invest. (1998) 101:2598–2605.
   PubMed Web of Science ®Google Scholar
• KIM PS, ARVAN P: Endocrinopathies in the family of en doplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr. Rev. (1998) 19:173–202.
   PubMed Web of Science ®Google Scholar
• ••A comprehensive review of Class II ER export diseases inendocrine disorders.
   Google Scholar
• PROCKOP DJ, KIVIRIKKO KI: Collagens: molecular biology, diseases and potentials for therapy. Ann. Rev. Biochem. (1995) 64:403–434.
   PubMed Web of Science ®Google Scholar
• HODES M, PRATT V, DLOUHY S: Genetics of Perlizaeus-Merzbacher disease. Devel. Neurosci. (1993) 15:383–394.
   PubMed Web of Science ®Google Scholar
• GOW A, LAZZARINI RA: A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nature Gen. (1996) 13:422–428.
   PubMed Web of Science ®Google Scholar
• GRIFFITHS I, KLUGMANN M, ANDERSON T et al.: Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (1998) 280:1610–1613.
   PubMed Web of Science ®Google Scholar
• DE JONGHE P, TIMMERMAN V, NELIS E, MARTIN J, VAN BROECKHOVEN C: Charcot-Marie-Tooth disease and related peripheral neuropathies. J. PNS (1997) 2:370–387.
   Google Scholar
• DURSO D, PRIOR R, GREINER-PETTER R, GABREELS-FESTEN AAWM, MULLER HW: Overloaded endoplasmic reticulum-golgi compartments, a possible pathome-chanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. Neurosci. (1998) 18:731–740.
   PubMed Web of Science ®Google Scholar
• SELKOE DJ: The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. (1998) 8:447–453.
   PubMed Web of Science ®Google Scholar
• DE STROOPER B, SAFTIG P, CRASESSAERTS K et al.: Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature (1998) 391:387–390.
   PubMed Web of Science ®Google Scholar
• DE STROOPER B, BEULLEN M, CONTRERAS B et al.:Phosphorylation, subcellular localization and membrane orientation of the Alzheimer's disease-associated persenilins. J. Biol. Chem. (1 9 9 7) 272:3590-3598.
   Google Scholar
• CULVENOR JD, MAHER F, EVIN G et al.: Alzheimer'sdisease associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-golgi intermediate compartment. J. Neurosci. Res. (1997) 49:719–731.
   PubMed Web of Science ®Google Scholar
• HAASS C, MANDELKOW E: Proeolysis by presenilinsand the renassance of tau. Trends Cell Biol. (1999) 9:241–244.
   PubMedGoogle Scholar
• COOK DG, FORMAN MS, SUNG JC et al.: Alzheimer'sABeta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nature Med. (1997) 3:1021–1023.
   PubMed Web of Science ®Google Scholar
• MATTSON MP, GUO Q, FURUKAWA K, PEDERSEN WA:Presenilins, the endoplasmic reticulum and neuronal apoptosis in Alzheimer's disease. J Neurochem. (1998) 70:1–14.
   PubMed Web of Science ®Google Scholar
• PLOEGH HL: Viral strategies of immune evasion.Science (1998) 280:248–253.
   PubMed Web of Science ®Google Scholar
• MARGOTTIN F, BOUR SP, DURAND H et al.: A novelhuman WD protein, h-betaTrCP, that interacts with 111V-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell (1998) 1:565–574.
   PubMed Web of Science ®Google Scholar
• DOEDENS JR, GIDDINGS TH, KIRKEGAARD K: Inhibi-tion of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis. J Virol (1997) 71:9054–9064.
   PubMed Web of Science ®Google Scholar
• LORD JM, ROBERTS LM: Toxin entry: retrograde transport through the secretory pathway. J Cell Biol. (1998) 140:733–736.
   PubMed Web of Science ®Google Scholar
• SIMPSON JC, DASCHER C, ROBERTS LM, LORD JM, BALCHWE: Ricin cytotoxicity is sensitive to recycling between the endoplasmic reticulum and the Golgi complex. J Biol. Chem. (1995) 270:20078–20083.
   PubMed Web of Science ®Google Scholar
• SANDVIG K, GARRED O, PRYDZ K et al.: Retrogradetransport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature (1992) 358:510–512.
   PubMed Web of Science ®Google Scholar
• SATO S, WARD CL, KROUSE ME, WINE JJ, KOPITO RR:Glycerol reverse the misfoldingphenotype of the most common cystic fibrosis mutation. J Biol. Chem. (1996) 271:635–638.
   PubMed Web of Science ®Google Scholar
• •This and [33] were the first demonstrations that AF508 folding could be reversed by a chemical chaparone in an in vitro cystic fibrosis model system.
   Google Scholar
• BROWN CR, HONG-BROWN LQ, BIWERSI J, VERKMAN AS, WELCH WJ: Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmem-brane conductance regulator protein. Cell Stress Chaper-ones (1996) 1:117–125.
   PubMed Web of Science ®Google Scholar
• •This and [32] were the first demonstrations that AF508 folding could be reversed by a chemical chaparone in an in vitro cystic fibrosis model system.
   Google Scholar
• QU BH, STRICKLAND EH, THOMAS PJ: localization and suppression of a kinetic defect in cystic fibrosis transmembrane conductance regulator folding. J Chem. (1997) 272:15739–15744.
   Web of Science ®Google Scholar
• BEBOK Z, VENGLARIK CJ, PANCZEL Z et al.: Activation of DeltaF508 CFIR in an epithelial monolayer. Am. J Physic)]. (1998) 275:C599–607.
   Google Scholar
• MORELLO JP, SALAHPOUR A, LAPERRIERE A et al: Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants [see comments]. j an. Invest. (2000) 105:887–895.
   PubMed Web of Science ®Google Scholar
• TAMARAPPOO BK, VERKMAN AS: Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J an. Invest. (1998) 101:2257–2267.
   PubMed Web of Science ®Google Scholar
• BURROWS JA, WILLIS LK, PERLMUTTER DH: Chemical chaperones mediate increased secretion of mutant alpha 1- antitrypsin (alpha 1-Al) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc. Natl. Acad. Sci. USA (2000) 97:1796–1801.
   PubMed Web of Science ®Google Scholar
• ZHOU Z, GONG Q, JANUARY CT: Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. pharmacol-ogical and temperature effects. J Biol. Chem. (1999) 274:31123–31126.
   Google Scholar
• LOO TVV, CLARKE DM: Correction of defective proteinkinesis of human p-glycoprotein mutants by substrates and modulators. J. Biol. Chem. (1997) 272:709–712.
   PubMed Web of Science ®Google Scholar
• RUBENSTEIN RC, ZEITLIN PL: Sodium 4-phenylbutyrate downreg-ulates Hsc70: implications for intracellular trafficking of DeltaF508-CFIR [see comments]. Am. J Physic)]. Cell Physiol. (2000) 278:C259–267.
   PubMed Web of Science ®Google Scholar
• RUBENSTEIN RC, ZEITLIN PL: A pilo t clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restora-tion of nasal epithelial CFIR function. Am]. Respir. Crit. Care Med. (1998) 157:484–490.
   PubMed Web of Science ®Google Scholar
• RUBENSTEIN RC, EGAN ME, ZEITLIN PL: In vitro pharma-cologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFHL Clin. Invest . (1997) 100:2457–2465.
   Google Scholar
• JIANG C, FANG SL, XIAO YF et al.: Partial restoration of cAMP-stimulated CFIR chloride channel activity in DeltaF508 cells by deoxysperg-ualin. Am. J Physiol. (1998) 275:C171–178.
   PubMedGoogle Scholar
• LOO MA, JENSEN TJ, CUI L et al.: Perturbation of Hsp90 interaction with nascent CFIRprevents its maturation and accelerates its degradation by the proteasome. EMBO J (1998) 17:6879–6887.
   PubMed Web of Science ®Google Scholar
• MEACHAM GC, PATTERSON C, ZHANG W, YOUNGER JM, CYR DM: The Hsc70 co-chaperone CHIP targets immature CFIR for proteasomal degradation. Nat. Cell Biol. (2001) 3:100–105.
   PubMed Web of Science ®Google Scholar
• MALIDE D, YEWDELL JW, BENNINK JR, CUSHMAN SW: The export of major histocompatibility complex class I molecules from the endoplasmic reticulum of rat brown adipose cells is acutely stimulated by insulin. Mot. Biol. Cell (2001) 12:101–114.
   PubMed Web of Science ®Google Scholar
• MACINTYRE S, SAMOLS D, DAILEY P: Two carboxyles-terases bind C-reactive protein within the endoplasmic reticulum and regulate its secretion during the acute phase response. J Biol. Chem. (1994) 269:24496–24503.
   PubMed Web of Science ®Google Scholar
• RIVERA VM, WANG X, WARDWELL S et al.: Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum [see comments]. Science (2000) 287:826–830.
   PubMed Web of Science ®Google Scholar
• ••First demonstration that the ER could be used as a regulatedsecretory compartment for the specific timed release of genetically enginered hormones of therapeutic relevance.
   Google Scholar
• LEE HC, KIM SJ, KIM KS, SHIN HC, YOON JW: Remission in models of Type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature (2000) 408:483–488.
   PubMed Web of Science ®Google Scholar
• ••Another demonstration that ER function can be utilised torelease a biologically active hormone (insulin analogue) and restore glucose levels in mouse diabetic models.
   Google Scholar
• MATLACK KE, MOTHES W, RAPOPORT TA: Protein translocation: tunnel vision. Cell (1998) 92:381–390.
   PubMed Web of Science ®Google Scholar
• TROMBETTA ES, HELENIUS A: Izctins as chaperones inglycoprotein folding. Curr. Opin. Struct. Biol. (1998) 8:587–592.
   PubMedGoogle Scholar
• LIU Y, CHOUDHURY P, CABRAL CM, SIFERS RN: Oligosac-charide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J Biol. Chem. (1999) 274:5861–5867.
   PubMed Web of Science ®Google Scholar
• HAMMOND C, HELENIUS A: Quality control in thesecretory pathway. CUIT. Opin. Cell Mel (1995) 7:523–529.
   PubMed Web of Science ®Google Scholar
• •Reviews the basic quality control pathways involved in ER export.
   Google Scholar
• BARLOWE C: COPII and selective export from the endoplasmic reticulum. Biochim. Biophys. Acta (1998) 1404:67–76.
   PubMed Web of Science ®Google Scholar
• KUEHN MJ, HERRMANN M, SCHEKMAN R: COPII-cargo interactions direct protein sorting into ER-derived transport vesicles. Nature (1998) 391:187–190.
   PubMed Web of Science ®Google Scholar
• ARIDOR M, WEISSMAN J, BANNYKH S, NOUFFER C, BALCH WE: Cargo selection by the COPII budding machinery during export from the endoplasmic reticulum. J. Cell Biol. (1998) 141:61–70.
   PubMed Web of Science ®Google Scholar
• BANNYKH SI, ROWE T, BALCH WE: Organization of endoplasmic reticulum export complexes. J Cell Biol. (1996) 135:19–35.
   PubMed Web of Science ®Google Scholar
• NISHIMURA N, BALCH WE: A di-acidic signal required for selective export from the endoplasmic reticulum. Science (1997) 277:556–558.
   PubMed Web of Science ®Google Scholar
• BAKER EK, COLLEY NJ, ZUKER CS: The cyclophilin homolog P.inaA functions as a chaperone, forming a stable complex in vivo with its protein target rhodopsin. EMBO J (1994) 13:4886–4895.
   Google Scholar
• KUVVANA T, PETERSON PA, KARLSSON L: Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation. PNAS USA (1998) 95:1056–1061.
   PubMed Web of Science ®Google Scholar
• SOMMER T, WOLF DH: Endoplasmic reticulum degrada-tion: reverse protein flow of no return. FASEBJ (1997) 11:1227–1233.
   PubMed Web of Science ®Google Scholar
• BRODSKY JL, MCCRACKEN AA: ER-associated andproteasome-mediated protein degradation: how two topologically restricted events came together. Trends Cell Biol. (1997) 7:151–156.
   PubMed Web of Science ®Google Scholar
• PLEMPER RK, WOLF DH: Retrograde protein transloca-tion: ERADication of secretory proteins in health and disease. Trends Biochem. Sci. (1999) 24:266–270.
   PubMed Web of Science ®Google Scholar
• •A general review of degradation pathways in the ER.
   Google Scholar
• CIECHANOVER A, ORIAN A, SCHWARTZ AL: Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays (2000) 22:442–451.
   PubMed Web of Science ®Google Scholar
• KOPITO RR: Aggresomes, inclusion bodies and proteinaggregation. Trends Cell Biol. (2000) 10:524–530.
   PubMed Web of Science ®Google Scholar
• BROWN MS, YE J, RAWSON RB, GOLDSTEIN JL: Regulatedintramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell (2000) 100:391–398.
   PubMed Web of Science ®Google Scholar
• TRAVERS KJ, PATIL CK, WODICKA L et al.: Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell (2000) 101:249–258.
   PubMed Web of Science ®Google Scholar
• CHAPMAN R, SIDRAUSKI C, WALTER P: Intracellular signaling from the endoplasmic reticulum to the nucleus. Ann. Rev. Cell Dev. Biol. (1998) 14:459–485.
   PubMed Web of Science ®Google Scholar
• HARDING HP, ZHANG Y, RON D: Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase [published erratum appears in Nature 1999 Mar 4;398(6722):90] [see comments]. Nature (1999) 397:271–274.
   PubMed Web of Science ®Google Scholar
• PAHL HL, BAEUERLE PA: Endoplasmic reticulum induced signal transduction and gene expression. Trends Cell Biol. (1997) 7:50–55.
   PubMed Web of Science ®Google Scholar
• PAHL HL, BAEUERLE PA: The ER-overload response:activation of NF-KB. Trends Cell Biol. (1997) 22:63–67.
   Google Scholar